UBS Group’s Silexion Therapeutics Corp Ordinary Shares SLXN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$88.5K	Buy	7,284 +2,426	+50%	+$29.5K	﹤0.01%	6063
2025 Q1	$80.2K	Buy	4,858 +3,868	+391%	+$63.8K	﹤0.01%	5941
2024 Q4	$29.9K	Buy	990 +878	+784%	+$26.5K	﹤0.01%	6382
2024 Q3	$7.91K	Buy	+112	New	+$7.91K	﹤0.01%	6659